Literature DB >> 26892320

Preventable Admissions on a General Medicine Service: Prevalence, Causes and Comparison with AHRQ Prevention Quality Indicators-A Cross-Sectional Analysis.

Krishna K Patel1, Nirav Vakharia2, James Pile2, Erik H Howell2,3, Michael B Rothberg2,4.   

Abstract

BACKGROUND: Rates of preventable admissions will soon be publicly reported and used in calculating performance-based payments. The current method of assessing preventable admissions, the Agency of Healthcare Research and Quality (AHRQ) Preventable Quality Indicators (PQI) rate, is drawn from claims data and was originally designed to assess population-level access to care.
OBJECTIVE: To identify the prevalence and causes of preventable admissions by attending physician review and to compare its performance with the PQI tool in identifying preventable admissions.
DESIGN: Cross-sectional survey.
SETTING: General medicine service at an academic medical center. PARTICIPANTS: Consecutive inpatient admissions from December 1-15, 2013. MAIN MEASURES: Survey of inpatient attending physicians regarding the preventability of the admissions, primary contributing factors and feasibility of prevention. For the same patients, the PQI tool was applied to determine the claims-derived preventable admission rate. KEY
RESULTS: Physicians rated all 322 admissions and classified 122 (38 %) as preventable, of which 31 (25 %) were readmissions. Readmissions were more likely to be rated preventable than other admissions (49 % vs. 35 %, p = 0.04). Application of the AHRQ PQI methodology identified 75 (23 %) preventable admissions. Thirty-one admissions (10 %) were classified as preventable by both methods, and the majority of admissions considered preventable by the AHRQ PQI method (44/78) were not considered preventable by physician assessment (K = 0.04). Of the preventable admissions, physicians assigned patient factors in 54 (44 %), clinician factors in 36 (30 %) and system factors in 32 (26 %).
CONCLUSIONS: A large proportion of admissions to a general medicine service appeared preventable, but AHRQ's PQI tool was unable to identify these admissions. Before initiation of the PQI rate for use in pay-for-performance programs, further study is warranted.

Entities:  

Keywords:  preventable admissions; quality indicators; value-based purchasing

Mesh:

Year:  2016        PMID: 26892320      PMCID: PMC4870420          DOI: 10.1007/s11606-016-3615-4

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  10 in total

1.  Risk factors for a medically inappropriate admission to a Department of Internal Medicine.

Authors:  T V Perneger; P Chopard; F P Sarasin; J M Gaspoz; C Lovis; P F Unger; A F Junod; F A Waldvogel
Journal:  Arch Intern Med       Date:  1997-07-14

2.  Rehospitalizations among patients in the Medicare fee-for-service program.

Authors:  Stephen F Jencks; Mark V Williams; Eric A Coleman
Journal:  N Engl J Med       Date:  2009-04-02       Impact factor: 91.245

3.  Expanding the uses of AHRQ's prevention quality indicators: validity from the clinician perspective.

Authors:  Sheryl Davies; Kathryn M McDonald; Eric Schmidt; Ellen Schultz; Jeffrey Geppert; Patrick S Romano
Journal:  Med Care       Date:  2011-08       Impact factor: 2.983

4.  Readmissions in the era of patient engagement.

Authors:  Jessica Howard-Anderson; Sarah Lonowski; Sitaram Vangala; Chi-Hong Tseng; Ashley Busuttil; Nasim Afsar-Manesh
Journal:  JAMA Intern Med       Date:  2014-11       Impact factor: 21.873

5.  The cost of inappropriate admissions: a study of health benefits and resource utilization in a department of internal medicine.

Authors:  B O Eriksen; I S Kristiansen; E Nord; J F Pape; S M Almdahl; A Hensrud; S Jaeger
Journal:  J Intern Med       Date:  1999-10       Impact factor: 8.989

6.  Classifying general medicine readmissions. Are they preventable? Veterans Affairs Cooperative Studies in Health Services Group on Primary Care and Hospital Readmissions.

Authors:  E Z Oddone; M Weinberger; M Horner; C Mengel; F Goldstein; P Ginier; D Smith; J Huey; N J Farber; D A Asch; L Loo; E Mack; A G Hurder; W Henderson; J R Feussner
Journal:  J Gen Intern Med       Date:  1996-10       Impact factor: 5.128

7.  Association between quality improvement for care transitions in communities and rehospitalizations among Medicare beneficiaries.

Authors:  Jane Brock; Jason Mitchell; Kimberly Irby; Beth Stevens; Traci Archibald; Alicia Goroski; Joanne Lynn
Journal:  JAMA       Date:  2013-01-23       Impact factor: 56.272

8.  Assessing the preventability of emergency hospital admissions. A method for evaluating the quality of medical care in a primary care facility.

Authors:  J Bigby; J Dunn; L Goldman; J B Adams; P Jen; C S Landefeld; A L Komaroff
Journal:  Am J Med       Date:  1987-12       Impact factor: 4.965

9.  Preventable hospitalizations and access to health care.

Authors:  A B Bindman; K Grumbach; D Osmond; M Komaromy; K Vranizan; N Lurie; J Billings; A Stewart
Journal:  JAMA       Date:  1995-07-26       Impact factor: 56.272

10.  The rate and cost of hospital readmissions for preventable conditions.

Authors:  Bernard Friedman; Jayasree Basu
Journal:  Med Care Res Rev       Date:  2004-06       Impact factor: 3.929

  10 in total
  12 in total

1.  More Challenges in Measuring Care Quality.

Authors:  Jodi B Segal
Journal:  J Gen Intern Med       Date:  2016-06       Impact factor: 5.128

2.  Predicting Risk of Potentially Preventable Hospitalization in Older Adults with Dementia.

Authors:  Donovan T Maust; H Myra Kim; Claire Chiang; Kenneth M Langa; Helen C Kales
Journal:  J Am Geriatr Soc       Date:  2019-06-18       Impact factor: 5.562

3.  Continuity of Care and Health Care Utilization in Older Adults With Dementia in Fee-for-Service Medicare.

Authors:  Halima Amjad; Donald Carmichael; Andrea M Austin; Chiang-Hua Chang; Julie P W Bynum
Journal:  JAMA Intern Med       Date:  2016-09-01       Impact factor: 21.873

4.  Characterizing Potentially Preventable Admissions: A Mixed Methods Study of Rates, Associated Factors, Outcomes, and Physician Decision-Making.

Authors:  Lisa M Daniels; Atsushi Sorita; Deanne T Kashiwagi; Masashi Okubo; Evan Small; Eric C Polley; Adam P Sawatsky
Journal:  J Gen Intern Med       Date:  2018-01-16       Impact factor: 5.128

5.  Annual Burden and Costs of Hospitalization for High-Need, High-Cost Patients With Chronic Gastrointestinal and Liver Diseases.

Authors:  Nghia H Nguyen; Rohan Khera; Lucila Ohno-Machado; William J Sandborn; Siddharth Singh
Journal:  Clin Gastroenterol Hepatol       Date:  2018-02-21       Impact factor: 11.382

6.  Spatial Patterns in Hospital-Acquired Infections in Portugal (2014-2017).

Authors:  Hugo Teixeira; Alberto Freitas; António Sarmento; Paulo Nossa; Hernâni Gonçalves; Maria de Fátima Pina
Journal:  Int J Environ Res Public Health       Date:  2021-04-28       Impact factor: 3.390

7.  What Is the Return on Investment of Caring for Complex High-need, High-cost Patients?

Authors:  Evelyn T Chang; Steven M Asch; Jessica Eng; Frances Gutierrez; Angela Denietolis; David Atkins
Journal:  J Gen Intern Med       Date:  2021-09-10       Impact factor: 5.128

8.  Burden and Outcomes of Fragmentation of Care in Hospitalized Patients With Inflammatory Bowel Diseases: A Nationally Representative Cohort.

Authors:  Nghia H Nguyen; Jiyu Luo; Lucila Ohno-Machado; William J Sandborn; Siddharth Singh
Journal:  Inflamm Bowel Dis       Date:  2021-06-15       Impact factor: 7.290

9.  Towards a patient journey perspective on causes of unplanned readmissions using a classification framework: results of a systematic review with narrative synthesis.

Authors:  R G Singotani; F Karapinar; C Brouwers; C Wagner; M C de Bruijne
Journal:  BMC Med Res Methodol       Date:  2019-10-04       Impact factor: 4.615

10.  Landscapes on Prevention Quality Indicators: A Spatial Analysis of Diabetes Preventable Hospitalizations in Portugal (2016-2017).

Authors:  Andre Ramalho; Mariana Lobo; Lia Duarte; Julio Souza; Paulo Santos; Alberto Freitas
Journal:  Int J Environ Res Public Health       Date:  2020-11-12       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.